Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

DSpace Repository

Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

Author: Mettke, F.; Schlevogt, B.; Deterding, K.; Wranke, A.; Smith, A.; Port, K.; Manns, M. P.; Vogel, A.; Cornberg, M.; Wedemeyer, H.
Tübinger Autor(en):
Wedemeyer, Heiner
Published in: Alimentary Pharmacology & Therapeutics (2018), Bd. 47, H. 4, S. 516-525
Verlagsangabe: Wiley
Language: English
Full text: http://dx.doi.org/10.1111/apt.14427
ISSN: 1365-2036
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)